Form4insider filings, from the source

SEC Form 4 · accession 0001477932-15-003515

Sun BioPharma, Inc. · SNBP

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Robert John Sargent
Director · 10% Owner
Period of report
Nov 21, 1996
Accepted (ET)
May 26, 2015 · 6:29 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001029125

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Class AF1Nov 21, 1996J120$0.00D0D
CommonF1Nov 21, 1996J214,286$0.00A214,286D
CommonF2Feb 8, 2001J120,000$0.00D94,286D
CommonF2Feb 8, 2001J120,000$0.00A120,000IBy Rare Principle, L.C.
CommonF3May 10, 2002S18,813$13.54D75,473D
CommonF3May 10, 2002S23,943$13.54D96,057IBy Rare Principle, L.C.
CommonF4Mar 31, 2005A120,000$0.01A195,473D
CommonF5Jun 1, 2008J195,473$0.00D0D
CommonF5Jun 1, 2008J195,473$0.00A291,530IBy Rare Principle, L.C.
Series A Preferred StockF6Mar 16, 2015P100,060$0.10A100,060IBy Rare Principle, L.C.

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses